Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Scheltens, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 97 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rombouts, SARB; Barkhof, F; Witter, MP; Machielsen, WCM; Scheltens, P
      Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: An event-related fMRI study

      NEUROIMAGE
    2. Scheltens, P
      Structural neuroimaging of Alzheimer's disease and other dementias

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    3. Head, MW; Tissingh, G; Uitdehaag, BMJ; Barkhof, F; Bunn, TJR; Ironside, JW; Kamphorst, W; Scheltens, P
      Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: Atypical molecular phenotype

      ANNALS OF NEUROLOGY
    4. Wahlund, LO; Barkhof, F; Fazekas, F; Bronge, L; Augustin, M; Sjogren, M; Wallin, A; Ader, H; Leys, D; Pantoni, L; Pasquier, F; Erkinjuntti, T; Scheltens, P
      A new rating scale for age-related white matter changes applicable to MRI and CT

      STROKE
    5. Galton, CJ; Gomez-Anson, B; Antoun, N; Scheltens, P; Patterson, K; Graves, M; Sahakian, BJ; Hodges, JR
      Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    6. Neele, SJM; Rombouts, SARB; Bierlaagh, MA; Barkhof, F; Scheltens, P; Netelenbos, JC
      Raloxifene affects brain activation patterns in postmenopausal women during visual encoding.

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    7. Sie, LTL; Rombouts, SARB; Valk, J; Hart, AAM; Scheltens, P; van der Knaap, MS
      Functional MRI of visual cortex in sedated 18 month-old infants with or without periventricular leukomalacia

      DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
    8. Rombouts, SARB; Orij, PCM; Scheltens, P
      A case study of functional MRI in dementia: methods to assess functions ofthe frontal cortex and the medial temporal lobe

      ALZHEIMERS REPORTS
    9. Berendse, HW; Verbunt, JPA; Scheltens, P; van Dijk, BW; Jonkman, EJ
      Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study

      CLINICAL NEUROPHYSIOLOGY
    10. Waldemar, G; Dubois, B; Emre, M; Scheltens, P; Tariska, P; Rossor, M
      Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe

      EUROPEAN JOURNAL OF NEUROLOGY
    11. Machielsen, WCM; Rombouts, SARB; Barkhof, F; Scheltens, P; Witter, MP
      fMRI of visual encoding: Reproducibility of activation

      HUMAN BRAIN MAPPING
    12. Witter, MP; Naber, PA; van Haeften, T; Machielsen, WCM; Rombouts, SARB; Barkhof, F; Scheltens, P; da Silva, FHL
      Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways

      HIPPOCAMPUS
    13. Barber, R; Gholkar, A; Scheltens, P; Ballard, C; McKeith, IG; O'Brien, JT
      MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    14. Rombouts, SARB; Barkhof, F; Witter, MP; Scheltens, P
      Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease

      NEUROSCIENCE LETTERS
    15. Erkinjuntti, T; Inzitari, D; Pantoni, L; Wallin, A; Scheltens, P; Rockwood, K; Roman, GC; Chui, H; Desmond, DW
      Research criteria for subcortical vascular dementia in clinical trials

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    16. Kuiper, MA; Teerlink, T; Visser, JJ; Bergmans, PLM; Scheltens, P; Wolters, EC
      L-Glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients

      JOURNAL OF NEURAL TRANSMISSION
    17. Lazeron, RHC; Rombouts, SARB; Machielsen, WCM; Scheltens, P; Witter, MP; Uylings, HBM; Barkhof, F
      Visualizing brain activation during planning: The Tower of London test adapted for functional MR imaging

      AMERICAN JOURNAL OF NEURORADIOLOGY
    18. Rombouts, SARB; Barkhof, F; Veltman, DJ; Machielsen, WCM; Witter, MP; Bierlaagh, MA; Lazeron, RHC; Valk, J; Scheltens, P
      Functional MR imaging in Alzheimer's disease during memory encoding

      AMERICAN JOURNAL OF NEURORADIOLOGY
    19. Wahlund, LO; Julin, P; Johansson, SE; Scheltens, P
      Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    20. Mulder, C; Scheltens, P; Visser, JJ; van Kamp, GJ; Schutgens, RBH
      Genetic and biochemical markers for Alzheimer's disease: recent developments

      ANNALS OF CLINICAL BIOCHEMISTRY
    21. Pijnenburg, YAL; Valk, J; Strijers, RLM; Jonkman, EJ; Scheltens, P
      Dementia in an elderly patient associated with extreme dilatation of the perivascular space

      ALZHEIMERS REPORTS
    22. Claus, JJ; Strijers, RLM; Jonkman, EJ; de Visser, BWO; Jonker, C; Walstra, GJM; Scheltens, P; van Gool, WA
      The diagnostic value of electroencephalography in mild senile Alzheimer' sdisease

      CLINICAL NEUROPHYSIOLOGY
    23. Rombouts, SARB; Scheltens, P; Machielsen, WCM; Barkhof, F; Hoogenraad, FGC; Veltman, DJ; Valk, J; Witter, MP
      Parametric fMRI analysis of visual encoding in the human medial temporal lobe

      HIPPOCAMPUS
    24. Wahlund, LO; Julin, P; Lindqvist, J; Scheltens, P
      Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry

      PSYCHIATRY RESEARCH-NEUROIMAGING
    25. Leys, D; Erkinjuntti, T; Desmond, DW; Schmidt, R; Englund, E; Pasquier, F; Parnetti, L; Ghika, J; Kalaria, RN; Chabriat, H; Scheltens, P; Bogousslavsky, J
      Vascular dementia: The role of cerebral infarcts

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    26. Pantoni, L; Leys, D; Fazekas, F; Longstreth, WT; Inzitari, D; Wallin, A; Filippi, M; Scheltens, P; Erkinjuntti, T; Hachinski, V
      Role of white matter lesions in cognitive impairment of vascular origin

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    27. Erkinjuntti, T; Bowler, JV; DeCarli, CS; Fazekas, F; Inzitari, D; O'Brien, JT; Pantoni, L; Rockwood, K; Scheltens, P; Wahlund, LO; Desmond, DW
      Imaging of static brain lesions in vascular dementia: Implications for clinical trials

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    28. Visser, PJ; Scheltens, P; Verhey, FRJ; Schmand, P; Launer, LJ; Jolles, J; Jonker, G
      Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

      JOURNAL OF NEUROLOGY
    29. Scheltens, P
      Early diagnosis of dementia: neuroimaging

      JOURNAL OF NEUROLOGY
    30. Harvey, GT; Hughes, J; McKeith, IG; Briel, R; Ballard, C; Gholkar, A; Scheltens, P; Perry, RH; Ince, P; O'Brien, JT
      Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study

      PSYCHOLOGICAL MEDICINE
    31. Barber, R; Gholkar, A; Scheltens, P; Ballard, C; McKeith, IG; O'Brien, JT
      Medial temporal lobe atrophy on MRI in dementia with Lewy bodies

      NEUROLOGY
    32. Van der Werf, YD; Weerts, JGE; Jolles, J; Witter, MP; Lindeboom, J; Scheltens, P
      Neuropsychological correlates of a right unilateral lacunar thalamic infarction

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    33. Barber, R; Gholkar, A; Scheltens, P; Ballard, C; McKeith, IG; Morris, CM; O'Brien, JT
      Apolipoprotein E epsilon 4 allele, temporal lobe atrophy, and white matterlesions in late-life dementias

      ARCHIVES OF NEUROLOGY
    34. Erkinjuntti, T; Inzitari, D; Pantoni, L; Wallin, A; Scheltens, P; Rockwood, K; Roman, G; Chui, H; Desmond, D
      Research criteria for subcortical vascular dementia in clinical trials

      1ST INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA
    35. VANDERWERF YD; WITTER MP; SCHELTENS P; JOLLES J
      LATERALIZATION OF NEUROPSYCHOLOGICAL EFFECTS AFTER LESIONS OF THE THALAMUS

      European journal of neuroscience
    36. Soininen, HS; Scheltens, P
      Early diagnostic indices for the prevention of Alzheimer's disease

      ANNALS OF MEDICINE
    37. ROMBOUTS SARB; BARKHOF F; HOOGENRAAD FGC; SPRENGER M; SCHELTENS P
      WITHIN-SUBJECT REPRODUCIBILITY OF VISUAL ACTIVATION PATTERNS WITH FUNCTIONAL MAGNETIC-RESONANCE-IMAGING USING MULTISLICE ECHO-PLANAR IMAGING

      Magnetic resonance imaging
    38. Scheltens, P; Hijdra, AH
      Diagnostic criteria for vascular dementia

      HAEMOSTASIS
    39. Pasquier, F; Leys, D; Scheltens, P
      The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease

      JOURNAL OF NEURAL TRANSMISSION
    40. VANWAESBERGHE JHTM; VANWALDERVEEN MAA; CASTELIJNS JA; SCHELTENS P; NIJEHOLT GJL; POLMAN CH; BARKHOF F
      PATTERNS OF LESION DEVELOPMENT IN MULTIPLE-SCLEROSIS - LONGITUDINAL OBSERVATIONS WITH T1-WEIGHTED SPIN-ECHO AND MAGNETIZATION-TRANSFER MR

      American journal of neuroradiology
    41. VELDINK JH; SCHELTENS P; JONKER C; LAUNER LJ
      PROGRESSION OF CEREBRAL WHITE-MATTER HYPERINTENSITIES ON MRI IS RELATED TO DIASTOLIC BLOOD-PRESSURE

      Neurology
    42. STEVENS M; VANDUIJN CM; KAMPHORST W; DEKNIJFF P; HEUTINK P; VANGOOL WA; SCHELTENS P; RAVID R; OOSTRA BA; NIERMEIJER MF; VANSWIETEN JC
      FAMILIAL AGGREGATION IN FRONTOTEMPORAL DEMENTIA

      Neurology
    43. ROMBOUTS SARB; LAZERON RHC; SCHELTENS P; UITDEHAAG BMJ; SPRENGER M; VALK J; BARKHOF F
      VISUAL ACTIVATION PATTERNS IN PATIENTS WITH OPTIC NEURITIS - AN FMRI PILOT-STUDY

      Neurology
    44. VANWALDERVEEN MAA; KAMPHORST W; SCHELTENS P; VANWAESBERGHE JHTM; RAVID R; VALK J; POLMAN CH; BARKHOF F
      HISTOPATHOLOGIC CORRELATE OF HYPOINTENSE LESIONS ON T1-WEIGHTED SPIN-ECHO MRI IN MULTIPLE-SCLEROSIS

      Neurology
    45. SCHELTENS P; ERKINJUNTI T; LEYS D; WAHLUND LO; INZITARI D; DELSER T; PASQUIER F; BARKHOF F; MANTYLA R; BOWLER J; WALLIN A; GHIKA J; FAZEKAS F; PANTONI L
      WHITE-MATTER CHANGES ON CT AND MRI - AN OVERVIEW OF VISUAL RATING-SCALES

      European neurology
    46. NIJEHOLT GJLA; VANWALDERVEEN MAA; CASTELIJNS JA; VANWAESBERGHE JHTM; POLMAN C; SCHELTENS P; ROSIER PFWM; JONGEN PJH; BARKHOF F
      BRAIN AND SPINAL-CORD ABNORMALITIES IN MULTIPLE-SCLEROSIS - CORRELATION BETWEEN MRI PARAMETERS, CLINICAL SUBTYPES AND SYMPTOMS

      Brain
    47. FAZEKAS F; SCHMIDT R; SCHELTENS P
      PATHOPHYSIOLOGIC MECHANISMS IN THE DEVELOPMENT OF AGE-RELATED WHITE-MATTER CHANGES OF THE BRAIN

      Dementia and geriatric cognitive disorders
    48. ERKINJUNTTI T; PANTONI L; SCHELTENS P
      COOPERATION AND NETWORKING ON WHITE-MATTER DISORDERS - THE EUROPEAN TASK-FORCE ON AGE-RELATED WHITE-MATTER CHANGES

      Dementia and geriatric cognitive disorders
    49. ROMBOUTS SARB; MACHIELSEN WCM; WITTER MP; BARKHOF F; LINDEBOOM J; SCHELTENS P
      VISUAL ASSOCIATION ENCODING ACTIVATES THE MEDIAL TEMPORAL-LOBE - A FUNCTIONAL MAGNETIC-RESONANCE-IMAGING STUDY

      Hippocampus
    50. SCHELTENS P
      MRI PATHOLOGY IN DEMENTIA AND ALZHEIMERS-DISEASE

      European journal of morphology
    51. SCHELTENS P; LAUNER LJ; BARKHOF F; WEINSTEIN HC; JONKER C
      THE DIAGNOSTIC-VALUE OF MAGNETIC-RESONANCE-IMAGING AND TECHNETIUM 99MHMPAO SINGLE-PHOTON-EMISSION COMPUTED-TOMOGRAPHY FOR THE DIAGNOSIS OFALZHEIMER-DISEASE IN A COMMUNITY-DWELLING ELDERLY POPULATION

      Alzheimer disease and associated disorders
    52. ANTUONO P; DOODY R; GILMAN S; HUFF J; SCHELTENS P; UEDA K; KHACHATURIAN ZS
      DIAGNOSTIC-CRITERIA FOR DEMENTIA IN CLINICAL-TRIALS - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUGGUIDELINES

      Alzheimer disease and associated disorders
    53. BODICK N; FORETTE F; HADLER D; HARVEY RJ; LEBER P; MCKEITH IG; RIEKKINEN PJ; ROSSOR MN; SCHELTENS P; SHIMOHAMA S; SPIEGEL R; TANAKA S; THAL LJ; URATA Y; WHITEHOUSE P; WILCOCK G
      PROTOCOLS TO DEMONSTRATE SLOWING OF ALZHEIMER-DISEASE PROGRESSION - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OFDEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    54. VANWAESBERGHE JHT; CASTELIJNS JA; SCHELTENS P; TRUYEN L; NIJEHOLT GJLA; HOOGENRAAD FG; POLMAN CH; VALK J; BARKHOF F
      COMPARISON OF 4 POTENTIAL MR PARAMETERS FOR SEVERE TISSUE DESTRUCTIONIN MULTIPLE-SCLEROSIS LESIONS

      Magnetic resonance imaging
    55. ROMBOUTS SARB; BARKHOF F; SPRENGER M; VALK J; SCHELTENS P
      THE FUNCTIONAL BASIS OF OCULAR DOMINANCE - FUNCTIONAL MRI (FMRI) FINDINGS (VOL 221, PG 1, 1996)

      Neuroscience letters
    56. BISSESSUR S; TISSINGH G; WOLTERS EC; SCHELTENS P
      RCBF SPECT IN PARKINSONS-DISEASE PATIENTS WITH MENTAL DYSFUNCTION

      Journal of neural transmission. Supplementum
    57. ROMBOUTS SARB; BARKHOF F; HOOGENRAAD FGC; SPRENGER M; VALK J; SCHELTENS P
      TEST-RETEST ANALYSIS WITH FUNCTIONAL MR OF THE ACTIVATED AREA IN THE HUMAN VISUAL-CORTEX

      American journal of neuroradiology
    58. NIJEHOLT GJLA; BARKHOF F; SCHELTENS P; CASTELIJNS JA; ADER H; VANWAESBERGHE H; POLMAN C; JONGEN SJH; VALK J
      MR OF THE SPINAL-CORD IN MULTIPLE-SCLEROSIS - RELATION TO CLINICAL SUBTYPE AND DISABILITY

      American journal of neuroradiology
    59. VANSWIETEN J; STEVENS M; RAVID R; KAMPHORST W; VANGOOL P; SCHELTENS P; VANDUIJN CM
      SPECTRUM OF CLINICAL ASPECTS IN FRONTOTEMPORAL DEMENTIA

      Neurology
    60. SCHELTENS P; VANGOOL WA
      EMERGING TREATMENTS IN DEMENTIA

      European neurology
    61. SCHELTENS P; PASQUIER F; WEERTS JGE; BARKHOF F; LEYS D
      QUALITATIVE ASSESSMENT OF CEREBRAL ATROPHY ON MRI - INTEROBSERVER ANDINTRAOBSERVER REPRODUCIBILITY IN DEMENTIA AND NORMAL AGING

      European neurology
    62. BARKHOF F; FILIPPI M; MILLER DH; SCHELTENS P; CAMPI A; POLMAN CH; COMI G; ADER HJ; LOSSEFF N; VALK J
      COMPARISON OF MRI CRITERIA AT FIRST PRESENTATION TO PREDICT CONVERSION TO CLINICALLY DEFINITE MULTIPLE-SCLEROSIS

      Brain
    63. STRIJERS RLM; SCHELTENS P; JONKMAN EJ; DERIJKE W; HOOIJER C; JONKER C
      DIAGNOSING ALZHEIMERS-DISEASE IN COMMUNITY-DWELLING ELDERLY - A COMPARISON OF EEG AND MRI

      Dementia and geriatric cognitive disorders
    64. ROMBOUTS SARB; BARKHOF F; SPRENGER M; VALK J; SCHELTENS P
      THE FUNCTIONAL BASIS OF OCULAR DOMINANCE - FUNCTIONAL MRI (FMRI) FINDINGS

      Neuroscience letters
    65. PASQUIER F; LEYS D; WEERTS JGE; MOUNIERVEHIER F; BARKHOF F; SCHELTENS P
      INTEROBSERVER AND INTRAOBSERVER REPRODUCIBILITY OF CEREBRAL ATROPHY ASSESSMENT ON MRI SCANS WITH HEMISPHERIC INFARCTS

      European neurology
    66. VANSOMEREN EJW; HAGEBEUK EEO; LIJZENGA C; SCHELTENS P; DEROOIJ SEA; JONKER G; POT AM; MIRMIRAN M; SWAAB DF
      CIRCADIAN REST-ACTIVITY RHYTHM DISTURBANCES IN ALZHEIMERS-DISEASE

      Biological psychiatry
    67. SCHELTENS P; LAUNER LJ; BARKHOF F; WEINSTEIN HC; VANGOOL WA
      VISUAL ASSESSMENT OF MEDIAL TEMPORAL-LOBE ATROPHY ON MAGNETIC-RESONANCE-IMAGING - INTEROBSERVER RELIABILITY

      Journal of neurology
    68. WIELAARD R; BORNEBROEK M; OPHOFF RA; WINTERWARNARS HAO; SCHELTENS P; FRANTS RR; FERRARI MD; HAAN J
      A 4-GENERATION DUTCH FAMILY WITH CEREBRAL AUTOSOMAL-DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY (CADASIL), LINKED TO CHROMOSOME 19P13

      Clinical neurology and neurosurgery
    69. LEYS D; SCHELTENS P; VERMERSCH P; PRUVO JP
      USEFULNESS OF MORPHOLOGICAL NEUROIMAGING TECHNIQUES IN THE DIAGNOSIS OF DEMENTIAS .2. VASCULAR DEMENTIAS

      La Revue de medecine interne
    70. SCHELTENS P; BARKHOF F; LEYS D; WOLTERS EC; RAVID R; KAMPHORST W
      HISTOPATHOLOGIC CORRELATES OF WHITE-MATTER CHANGES ON MRI IN ALZHEIMERS-DISEASE AND NORMAL AGING

      Neurology
    71. LAUNER LJ; SCHELTENS P; LINDEBOOM J; BARKHOF F; WEINSTEIN HC; JONKER C
      MEDIAL TEMPORAL-LOBE ATROPHY IN AN OPEN POPULATION OF VERY OLD PERSONS - COGNITIVE, BRAIN ATROPHY, AND SOCIOMEDICAL CORRELATES

      Neurology
    72. KONINGS CH; SCHELTENS P; KUIPER MA; WOLTERS EC
      NO EVIDENCE FOR ABNORMALITIES IN KINETICS OF PLATELET MONOAMINE-OXIDASE IN ALZHEIMERS-DISEASE

      Clinica chimica acta
    73. LEYS D; MOUNIERVEHIER F; RONDEPIERRE P; LECLERC X; GODEFROY O; MARCHAU M; SCHELTENS P; PRUVO JP
      SMALL INFARCTS IN THE CENTRUM OVALE - STUDY OF PREDISPOSING FACTORS

      Cerebrovascular diseases
    74. KUIPER MA; MULDER C; VANKAMP GJ; SCHELTENS P; WOLTERS EC
      CEREBROSPINAL-FLUID FERRITIN LEVELS OF PATIENTS WITH PARKINSONS-DISEASE, ALZHEIMERS-DISEASE, AND MULTIPLE SYSTEM ATROPHY

      Journal of neural transmission. Parkinson's disease and dementia section
    75. BOERMAN RH; SCHELTENS P; WEINSTEIN HC
      CLINICAL NEUROPHYSIOLOGY IN THE DIAGNOSIS OF ALZHEIMERS-DISEASE

      Clinical neurology and neurosurgery
    76. BARKHOF E; KOUWENHOVEN M; SCHELTENS P; SPRENGER M; ALGRA P; VALK J
      PHASE-CONTRAST CINE MR-IMAGING OF NORMAL AQUEDUCTAL CSF FLOW - EFFECTOF AGING AND RELATION TO CSF VOID ON MODULUS MR

      Acta radiologica
    77. SCHELTENS P; LEYS D; BARKHOF F; VERMERSCH P; STEINLING M; WEINSTEIN HC; PRUVO JP; PETIT H
      USEFULNESS OF MORPHOLOGICAL NEUROIMAGING TECHNIQUES IN THE DIAGNOSIS OF DEMENTIAS .1. ALZHEIMERS-DISEASE

      La Revue de medecine interne
    78. LAUNER LJ; SCHELTENS P; LINDEBOOM J; BARKHOF F; WEINSTEIN H; JONKER C
      COGNITIVE, BRAIN ATROPHY AND SOCIOMEDICAL CORRELATES OF HIPPOCAMPAL ATROPHY IN AN OPEN POPULATION OF OLD PERSONS

      Neurobiology of aging
    79. WALLIN A; BLENNOW K; SCHELTENS P
      CRITERIA FOR DIAGNOSIS OF PURE ALZHEIMERS-DISEASE

      Neurobiology of aging
    80. BARKHOF F; TAS MW; FREQUIN STFM; SCHELTENS P; HOMMES OR; NAUTA JJP; VALK J
      LIMITED DURATION OF THE EFFECT OF METHYLPREDNISOLONE ON CHANGES ON MRI IN MULTIPLE-SCLEROSIS

      Neuroradiology
    81. SCHELTENS P; LAUNER LJ; WEINSTEIN HC; BARKHOF F; JONKER C
      THE VALUE OF MRI AND SPECT IN THE EARLY DIAGNOSIS OF ALZHEIMERS-DISEASE

      Neurology
    82. SCHELTENS P; RAVID R; KAMPHORST W
      PATHOLOGICAL FINDINGS IN A CASE OF PRIMARY PROGRESSIVE APHASIA

      Neurology
    83. BRUYN RPM; VANDIJK JG; SCHELTENS P; BOEZEMAN EHJF; DEVISSER BWO
      CLINICALLY SILENT DYSFUNCTION OF DORSAL COLUMNS AND DORSAL SPINOCEREBELLAR TRACTS IN HEREDITARY SPASTIC PARAPARESIS

      Journal of the neurological sciences
    84. KUIPER MA; VISSER JJ; BERGMANS PLM; SCHELTENS P; WOLTERS EC
      DECREASED CEREBROSPINAL-FLUID NITRATE LEVELS IN PARKINSONS-DISEASE, ALZHEIMERS-DISEASE AND MULTIPLE SYSTEM ATROPHY PATIENTS

      Journal of the neurological sciences
    85. VERMERSCH P; LEYS D; SCHELTENS P; BARKHOF F
      VISUAL RATING OF HIPPOCAMPAL ATROPHY - CORRELATION WITH VOLUMETRY

      Journal of Neurology, Neurosurgery and Psychiatry
    86. VERMERSCH P; SCHELTENS P; BARKHOF F; STEINLING M; LEYS D
      EVIDENCE FOR ATROPHY OF THE CORPUS-CALLOSUM IN ALZHEIMERS-DISEASE

      European neurology
    87. KONINGS CH; SCHELTENS P; KUIPER MA; MULDER C; CALLIAUW J; WOLTERS EC
      CEREBROSPINAL-FLUID ACETYLCHOLINESTERASE HOMOSPECIFIC ACTIVITY IN PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE

      Biological psychiatry
    88. KONINGS CH; KUIPER MA; SCHELTENS P; GRIJPMA AM; VANPELT W; WOLTERS EC
      REEVALUATION OF CEREBROSPINAL-FLUID ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE

      European journal of clinical chemistry and clinical biochemistry
    89. KUIPER MA; VANKAMP GJ; BERGMANS PLM; SCHELTENS P; WOLTERS EC
      SERUM ALPHA-1-ANTICHYMOTRYPSIN IS NOT A USEFUL MARKER FOR ALZHEIMERS-DISEASE OR DEMENTIA IN PARKINSONS-DISEASE

      Journal of neural transmission. Parkinson's disease and dementia section
    90. WEINSTEIN HC; SCHELTENS P; HIJDRA A; VANROYEN EA
      NEURO-IMAGING IN THE DIAGNOSIS OF ALZHEIMERS-DISEASE .2. POSITRON ANDSINGLE-PHOTON EMISSION TOMOGRAPHY

      Clinical neurology and neurosurgery
    91. DEWAAL R; ALGRA PR; HEIMANS JJ; WOLBERS JG; SCHELTENS P
      METHOTREXATE-INDUCED BRAIN NECROSIS AND SEVERE LEUKOENCEPHALOPATHY DUE TO DISCONNECTION OF AN OMMAYA DEVICE

      Journal of neuro-oncology
    92. BRUYN RPM; HAGEMAN G; GEELEN JAG; VANDERWEEL FA; ROZEBOOM AR; BARKHOF F; SCHELTENS P
      SPECT, CT AND MRI IN A TURKISH FAMILY WITH HUNTINGTONS-DISEASE

      Neuroradiology
    93. SCHELTENS P; KAMPHORST W; BARKHOF F; WOLTERS EC; RAVID R; LEYS D
      PATHOLOGICAL CORRELATIONS OF WHITE MATTER CHANGES ON MRI IN ALZHEIMERS-DISEASE AND NORMAL AGING

      Neurology
    94. BARKHOF F; SCHELTENS P; KAMPHORST W
      PREMORTEM AND POSTMORTEM MR-IMAGING OF UNSUSPECTED MULTIPLE-SCLEROSISIN A PATIENT WITH ALZHEIMERS-DISEASE

      Journal of the neurological sciences
    95. TORENBEEK R; SCHELTENS P; VANSCHIJNDEL RJMS; ALGRA PR; HEIMANS JJ; VANDERVALK P
      ANGIOTROPIC INTRAVASCULAR LARGE-CELL LYMPHOMA WITH MASSIVE CEREBRAL EXTENSION

      Journal of Neurology, Neurosurgery and Psychiatry
    96. TORREMAN M; SMIT LME; VANDERVALK P; VALK J; SCHELTENS P
      A CASE OF MACROCEPHALY, HYDROCEPHALUS, MEGACEREBELLUM, WHITE-MATTER ABNORMALITIES AND ROSENTHAL FIBERS

      Developmental Medicine and Child Neurology
    97. BRUYN RPM; SCHELTENS P; NIJEHOLT JLA; DEJONG JMBV
      AUTOSOMAL RECESSIVE PARAPARESIS WITH AMYOTROPHY OF THE HANDS AND FEET

      Acta neurologica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 09:42:23